SurModics, Inc. (SRDX) - Product Pipeline Analysis, 2016 Update

Date: March 9, 2016
Pages: 39
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S25A55F0924EN
Leaflet:

Download PDF Leaflet

SurModics, Inc. (SRDX) - Product Pipeline Analysis, 2016 Update
Summary

SurModics, Inc. (SurModics) is a provider of drug delivery and in vitro diagnostic technologies. The company offers wide range of advanced technologies that includes drug delivery technologies and surface modification coating technologies. Its technologies are employed in the development of new medical devices, biomedical products and in the enhancement of existing products and devices. SurModics commercializes its technologies through licensing and royalty arrangements with medical device manufacturers. SurModics sells components for in vitro diagnostic test kits and microarrays; and manufactures and distributes surface coatings to the diagnostic and biomedical research markets. The company has a wide distribution network across the world. SurModics is headquartered in Minnesota, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company SurModics, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

    Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
  • SurModics, Inc. Company Snapshot
    SurModics, Inc. Company Overview
    Key Information
    SurModics, Inc. Pipeline Products and Clinical Trials Overview
    SurModics, Inc. – Pipeline Analysis Overview
    Business Description
    SurModics, Inc. - Major Products and Services
    SurModics, Inc. Pipeline Products by Development Stage
    SurModics, Inc. Clinical Trials by Trial Status
    SurModics, Inc. Pipeline Products Overview
    0.018” OTW Dual Lumen PTA Catheter
    0.018” OTW Dual Lumen PTA Catheter Product Overview
    0.018” RX Dual Lumen PTA Catheter
    0.018” RX Dual Lumen PTA Catheter Product Overview
    0.035” Large Diameter OTW PTA Catheter
    0.035” Large Diameter OTW PTA Catheter Product Overview
    0.035” Next Generation Workhorse PTA Catheter
    0.035” Next Generation Workhorse PTA Catheter Product Overview
    I-vation Sustained Drug Delivery System - TA
    I-vation Sustained Drug Delivery System - TA Product Overview
    Neuraxo Implant
    Neuraxo Implant Product Overview
    Renal Stent System
    Renal Stent System Product Overview
    SurVeil Drug Coated Balloon - Arterio Venous (AV) Fistulas
    SurVeil Drug Coated Balloon - Arterio Venous (AV) Fistulas Product Overview
    SurVeil Drug Coated Balloon - Below The Knee (BTK)
    SurVeil Drug Coated Balloon - Below The Knee (BTK) Product Overview
    SurVeil Drug Coated Balloon - Coronary
    SurVeil Drug Coated Balloon - Coronary Product Overview
    SurVeil Drug Coated Balloon - SFA
    SurVeil Drug Coated Balloon - SFA Product Overview
    SurVeil Drug Coated Balloon - SFA Clinical Trial
    SurModics, Inc. - Key Competitors
    SurModics, Inc. - Key Employees
    SurModics, Inc. - Key Employee Biographies
    SurModics, Inc. - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Recent Developments
    SurModics, Inc., Recent Developments
    Jan 28, 2016: SurModics Reports First Quarter Fiscal 2016 Results
    Jan 08, 2016: SurModics Provides Updated 2016 Guidance
    Dec 22, 2015: SurModics Announces Device Veteran Shawn McCormick Joins Board of Directors
    Nov 10, 2015: SurModics Reports Fourth Quarter Fiscal 2015 Results
    Oct 05, 2015: SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil Drug-Coated Balloon
    Oct 05, 2015: SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil Drug-Coated Balloon
    Aug 05, 2015: SurModics Reports Third Quarter Fiscal 2015 Results
    Apr 30, 2015: SurModics Reports Second Quarter Fiscal 2015 Results
    Mar 06, 2015: SurModics Announces New Board Chair
    Feb 05, 2015: SurModics Announces Gerald B. Fischer’s Retirement from Board of Directors
    Appendix
    Methodology
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    SurModics, Inc., Key Facts
    SurModics, Inc. Pipeline Products and Clinical Trials Overview
    SurModics, Inc. Pipeline Products by Equipment Type
    SurModics, Inc. Pipeline Products by Indication
    SurModics, Inc. Clinical Trials by Trial Status
    SurModics, Inc., Major Products and Services
    SurModics, Inc. Number of Pipeline Products by Development Stage
    SurModics, Inc. Pipeline Products Summary by Development Stage
    SurModics, Inc. Clinical Trials by Trial Status
    SurModics, Inc. Clinical Trials Summary
    0.018” OTW Dual Lumen PTA Catheter - Product Status
    0.018” OTW Dual Lumen PTA Catheter - Product Description
    0.018” RX Dual Lumen PTA Catheter - Product Status
    0.018” RX Dual Lumen PTA Catheter - Product Description
    0.035” Large Diameter OTW PTA Catheter - Product Status
    0.035” Large Diameter OTW PTA Catheter - Product Description
    0.035” Next Generation Workhorse PTA Catheter - Product Status
    0.035” Next Generation Workhorse PTA Catheter - Product Description
    I-vation Sustained Drug Delivery System - TA - Product Status
    I-vation Sustained Drug Delivery System - TA - Product Description
    Neuraxo Implant - Product Status
    Neuraxo Implant - Product Description
    Renal Stent System - Product Status
    Renal Stent System - Product Description
    SurVeil Drug Coated Balloon - Arterio Venous (AV) Fistulas - Product Status
    SurVeil Drug Coated Balloon - Arterio Venous (AV) Fistulas - Product Description
    SurVeil Drug Coated Balloon - Below The Knee (BTK) - Product Status
    SurVeil Drug Coated Balloon - Below The Knee (BTK) - Product Description
    SurVeil Drug Coated Balloon - Coronary - Product Status
    SurVeil Drug Coated Balloon - Coronary - Product Description
    SurVeil Drug Coated Balloon - SFA - Product Status
    SurVeil Drug Coated Balloon - SFA - Product Description
    SurVeil Drug Coated Balloon - SFA - A Prospective, Multi-center, Single-arm Trial to Assess the Safety and Feasibility of the SurModics Drug Coated Balloon in the Treatment of Subjects with De Novo Lesions of the Femoropopliteal Artery
    SurModics, Inc., Key Employees
    SurModics, Inc., Key Employee Biographies
    SurModics, Inc., Subsidiaries

    LIST OF FIGURES

    SurModics, Inc. Pipeline Products by Equipment Type
    SurModics, Inc. Pipeline Products by Development Stage
    SurModics, Inc. Clinical Trials by Trial Status
    Skip to top


    Ask Your Question

    SurModics, Inc. (SRDX) - Product Pipeline Analysis, 2016 Update
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: